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Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are common medications used
by the general population due their anti-inflammatory and analgesic properties. These
are especially popular in athletes since they are not prohibited in many rules of athletic
competition.

Over-the-counter (OTC) NSAIDs comprise several drugs that may be

purchased without a prescription.

These are often over-utilized by the general population

due to their accessibility and relatively low cost. The unsuspecting victims are the
children, especially adolescent athletes, who deem OTC NSAIDs safe without realizing
the potential adverse effects of inappropriate consumption of these medications. This
article reviews the approved indications and side effects ofNSAIDs as well as the
literature that reveals the overuse and potential complications ofNSAIDs in adolescents
with recommendations to minimize injury.

Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are often the drugs-of-choice
for acute injuries (i.e. sprains and strains) due to their anti-inflammatory and analgesic
properties.

I

The use ofNSAIDs across a wide range of sports'? has been reported, and

NSAIDs are touted as one of the drug classes most often used by athletes.5 Certain
NSAIDs including aspirin, ibuprofen, ketoprofen, and naproxen are available over-thecounter (OTC) which allows the patients to obtain the medication without the need of a
prescription.

Over-the-counter NSAIDs are easily accessible and relatively low-cost;

appearing to be a quick solution to sprains and strains experienced in athletic training.
The use of these medications is legal in competition and since no prescription is required
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for OTC NSAIDs, many people, including high school athletes, deem them safe to use
without realizing the potential adverse effects stemming from inappropriate use of these
medications.

6

Many case reports of adolescents have been reported about the serious

and possibly life-threatening effects of NSAIDs, including acute and chronic renal
failure.7
The problem is the lack of education and understanding by adolescents about the
dangers ofNSAID use. Many case reports have clearly established that children can
experience serious, if not sentinel, events with NSAID use. This article reviews the
frequency and awareness of OTC NSAID use by athletes and reports the adverse effects
from these medications in athletes and children. By providing guidelines for OTC
NSAID use, adolescents will understand the appropriate and safer use of these drugs that
will then be carried on into adulthood.
NSAID Overview and Mechanism of Action
NSAIDs are comprised of a wide selection of agents with different
pharmacodynamics,

pharmacokinetics, indications, and formulations. Over-the-counter

NSAIDs are only orally administered and limited to aspirin, ibuprofen, ketoprofen, and
naproxen.'

To achieve their desired anti-inflammatory and analgesic properties,

NSAIDs work by blocking cyclooxygenase (COX) which in turn inhibits prostaglandin
synthesis from arachidonicacid."

As Figure 1 illustrates, NSAIDs reversibly block two

isoenzymes: a constitutive form called COX-l and an inducible form called COX-2.
Inhibition of the COX-2 enzyme reduces the inflammatory response from injury while
blocking the COX-l enzyme is responsible for gastrointestinal and renal side effects of
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NSAIDs. Selective COX-2 NSAIDs are agents that only block COX-2 isoenzyme,
thereby theoretically avoiding mainly gastrointestinal and some kidney complications.
COX-2 is also implicated in other physiologic process including renal function and tissue
.

repair.

!O

FDA Approved Indications
Based on their therapeutic effects, NSAIDs are approved and labeled for an
assortment of inflammatory conditions as well as mild-to-moderate pain, and fever.!!
The two main OTC NSAIDs used by the general public are ibuprofen (Advil® or
Motrin®) and naproxen (Aleve®) and are available at lower doses than the prescription
products, 200 milligrams and 220 milligrams respectively per tablet, capsule, or caplet.
For conditions that require higher strength NSAIDs, a prescription is usually warranted;
however, many athletes have resorted to using OTC NSAIDs for unlabeled indications
and in quantities surpassing the recommended daily amount according to OTC directions.

Misuse of NSAIDs
Due to their permissible use in competition, accessibility, low-cost, and
therapeutic benefit, athletes frequently take NSAIDs to continue their daily activities.
They have been reported to self-medicate with OTC NSAIDs to return to their respective
sport or training at an accelerated pace.f As well, athletes use them as a preventive
measure to avoid injury even though the drugs have not been indicated for this.
Survey studies have reported participants' responses point toward NSAID overuse.
For example, Canadian athletes used NSAIDs more than any other medication in the
2000 Sydney Olympic Games.9 Huang et al.!2 also surveyed Canadian athletes in the
3

1996 and 2000 Olympic Games for NSAID use and found that it was reported by 33%
and 38% of the athletes, respectively.
Gorski et a1.1 surveyed the 2008 Brazil Ironman triathletes for NSAID use and
awareness of the drugs' effects. Of the 1250 participants, 327 athletes were enrolled in
the study. Of the enrolled subjects, over half (59.9%) reported NSAID use in the
previous three months. Pain prevention during the race was the main reason cited for
taking NSAIDs one day prior to race day, immediately before the race, and during the
competition.

When awareness ofNSAID effects was assessed, the authors discovered the

majority of athletes were generally unknowledgeable of adverse effects. Gastrointestinal
complications were the most familiar side effect with 58.7% (n

=

192) of respondents

listing it as a concern while kidney failure was identified as a possible consequence in
only 18.3% (n = 60) of the athletes.
Animal studies have shown some benefit of the use of NSAIDs prior to artificiallyinduced muscle insult, but have not suggested any evidence for benefit for prophylaxis to
muscle injury owing to physical activity.

13

Even in human studies, results remain

ambiguous for prophylactic NSAID use and only conclude that further studies are needed
in athletes to fully assess NSAID potential in preventative care. 13
In Table I, Warden et a1.13 provides a comparison of the risks versus benefits for

the prophylactic use ofNSAIDs by athletes. This unsupported use ofNSAIDs occurs not
only in elite athletes, but also in young athletes. Tscholl et aI.2 investigated the use and
possible abuse of analgesics with adult female and male youth soccer players in six
Federation Internationale de Football Association (FIF A) tournaments. Surprisingly,
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approximately one in six (17.3%) players under 17 years, one in five (21.4%) players
under 20 years, and one in three (30.7%) female players took NSAIDs before a match.
Of all the players combined, 8.9% (209 of 2340) used at least two formulations of
NSAIDs. The topical route was the least popular preparation with use at 0.6% even
though topical applications have the least amount of systemic adverse reactions.
Warner et a1.6 assessed NSAID use and attitude among high school athletes. The
authors provided a self-administered questionnaire to 681 high school football players
with a mean age of 15.8 years. Their answers revealed that nearly one in seven of these
adolescent athletes used NSAIDs daily, and 75% (n

=

432) had used NSAIDs within the

past three months. The majority of daily users (91 %) believed NSAIDs improved their
performance even though the drugs are not considered performance enhancers. The
authors concluded that the adolescents that were most likely to use NSAIDs daily were
those who believed they performed better with the medications, those who decided on
their own when to take NSAIDs, and those who used the drugs to block pain as a
preventative measure instead of treating the pain that was inflicted. The survey did not
assess the athletes' awareness of either therapeutic benefits or side effects of NSAIDs.

Adverse Effects
Besides underlining the overuse of NSAIDs, the above surveys also highlight the
observation that athletes are unaware of the potential adverse effects from NSAIDs. The
most common, and well-known, side effects involve the gastrointestinal (GI) tract to
inhibition of GI protective prostaglandins.

I

Minor insults affecting anywhere between 10

to 60% of users include nausea, dyspepsia, flatulence, anorexia, abdominal pain, and
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diarrhea.lo

These effects can be reduced ifNSAIDs are taken with food or milk or with

enteric coated NSAIDs, which should not be taken with milk or antacids. More serious
GI problems consist of gastric or duodenal bleeding or ulceration, perforation, and gastric
outlet obstruction. These occur in 1.5 to 4% of persons per year which amounts to
substantial morbidity and mortality considering NSAIDs' widespread use.IO The risks
increase in the geriatric population, those with a history of ulcers or GI bleeding,
smokers, frequency of alcohol consumption, and comorbid conditions like cardiovascular
disease.

II

Long duration ofNSAID use, large NSAID dose, and number of agents

concomitantly administered also augment the risk for GI side effects as well as other
adverse reactions.
Non-steroidal anti-inflammatory drugs also increase the risk of cardiovascularrelated events, including myocardial infarction. Although these cardiovascular (CV)
risks were considered to be more associated with COX-2 selective NSAIDs, new Food
and Drug Administration (FDA) guidelines have mandated new labeling on all NSAIDs.
Newer studies have indicated a possible increase in CV events with more widely used
NSAIDs such as ibuprofen.

14

Even though these risks are more related to older age,

Fosbol et a1.15 demonstrated an increase in myocardial infarction in young healthy
individuals aged 30 to 50 years with NSAID use. Although the risk was low (63 deaths
per 1,000,000 person-years), the outcomes were serious, creating more controversy on
the prophylactic use of NSAIDs in athletes.
Athletes often take NSAIDs so as to be able to continue training in their
respective field, but another potential side effect of continual NSAID use is delay in
musculoskeletal tissue healing. Prostaglandins mediated by COX-2 are required for
6

muscle regeneration.
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Short-term use ofNSAIDs will provide anti-inflammatory,

analgesic properties that will promote return of function of injured tissue. However,
prolonged use may delay tissue-level healing.!" Trappe et al. 18 studied post exercise (24
hours) skeletal muscle fractional synthesis rate (FSR) in male subjects. Over-the-counter
doses of ibuprofen compared with placebo showed unchanged FSR while the placebo
group had increased FSR. The potential for reduction in muscle hypertrophy following
injury or exercise challenges the basis of athletes for prophylactic use ofNSAIDs.
NSAIDs may also cause kidney injury such as acute or chronic renal
insufficiency, hyperkalemia, renal papillary necrosis, and interstitial nephritis.

10

These

insults are from direct toxicities of NSAIDs and their inhibition of prostaglandins that
promote vasodilation of renal blood vessels thereby, decreasing perfusion throughout the
kidneys. Although the people most at risk are the elderly, certain comorbidities are
associated with decreased renal blood flow such as in congestive heart failure and chronic
renal insufficiency, and potentially nephrotoxic drugs, such as diuretics,
aminoglycosides,

angiotensin-converting

enzyme inhibitors and ethanol. I I Healthy

athletes, especially adolescents, probably do not have these risk factors, but they are
frequently dehydrated due to fluid loses during intense exercise. Volume depletion along
with stress from strenuous activities promotes the development of renal diseases while on
NSAIDs.

13

Renal injuries from NSAIDs are becoming more common in children and

adolescents and the following case studies indicate that proper education needs to be
implemented to ensure safe use of accessible OTe NSAIDs.

7

Case Studies
Renal complications are a growing concem among children and adolescents.
Acute kidney injury (AKI) occurring in healthy adolescents leads to the conclusion that
NSAIDs are not as safe as the general public perceives. Table 2 summarizes case studies
involving children and adolescents with renal complications due to NSAIDs.
Nakahura et al.? reported a 16-year-old female who took ibuprofen periodically
for headaches. She was admitted to the hospital for persistent flank pain and fever,
unresponsive to intravenous antibiotics. Interstitial nephritis was determined upon a
kidney biopsy. She was treated with oral steroids for 2 months and discontinuation of the
ibuprofen was recommended.

One year later, she was asymptomatic and her serum

creatinine decreased from 2.6mg/dl initially to 1.2mg/dl. However, two years after initial
treatment, her serum creatinine increased to 2.8mg/dl and chronic renal failure ensued

/

when interstitial fibrosis was discovered on her repeat kidney biopsy.
Becker-Cohen et al.19 described a rare occurrence ofnaproxen-associated

acute

interstitial nephritis (AIN) developing into severe reversible renal failure. AIN occurred
in a 10-year-old girl who took one month of naproxen followed by diclofenac for juvenile
rheumatoid arthritis. After discontinuation of naproxen and diclofenac, administration of
methylprednisolone

and tapering prednisone therapy, her 6th month follow-up showed

resolution of AIN.
Ulinski et a1.2oreported six children aged 4 to 15 years who presented with
diarrhea and/or vomiting and fever. They were treated for their fever with therapeutic
doses of ibuprofen before developing AKI. This case review emphasized the potential
8

danger ofNSAIDs in instances of even mild volume depletion. These case studies stress
the importance of education about the toxicity of OTC NSAIDs, even in small amounts.

Recommendations
Over-the-counter NSAIDs can be safely administered if used for short periods of
time and with proper dosing according to their labeling. These medications should be
taken with food to avoid GI upset and with fluids to avoid dehydration and renal
complications.

Appropriate indications should be followed and prophylactic doses

should be avoided. If possible, oral NSAIDs should be substituted for topical products to
avoid systemic adverse effects. A non-pharmacologic therapy to be considered is the
RICE protocol. RICE stands for rest, ice, compression, and elevation and tries to prevent
injury-induced bleeding into the muscle so to minimize the extent of an injury. If an acute
injury occurs, taking time off from activities, icing the area on and off for 20 minutes,
wrapping the affected area in a compression bandage, and keeping the area above heart
level might prove beneficial.

21

Conclusion
Over-the-counter NSAIDs are a frequently used medication for athletes,
especially adolescents due to their anti-inflammatory and analgesic therapeutic
properties. They are easily accessible and are generally safe and effective when used as
directed for short durations. Overuse ofNSAIDs is a frequent occurrence across sports,
gender, and age. Even with existing evidence in adults and children of the detrimental
effects ofNSAIDs, serious complications are overlooked. To prevent adverse effects and
promote healthy healing in athletes, education on NSAID complications and appropriate
9

use needs to be encouraged and supported by all athletes, healthcare professionals, and
role models to adolescents.
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Figure 1
Mechanism of Action ofNSAIDs22
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Table 1 Perceived Benefits and Potential Risks of Prophylactic and Frequent Use of
NSAIDs by Athletes 13
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Table2 NSAID-Associated Adverse Events in Children
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